How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Feb 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How Venture Capitalists Are Deforming Capitalism

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Dec 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analysts forecast LS tech and business trend of 2022

Nov 23
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI Software Market Set to Reach New Heights Next Year

Oct 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Global data and analysis on dealmaking, funding, and exits in private-market companies

Dec 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analyst shares the impact of ML applications in LS

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Dec 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

VC investors share AI's impact on LS industries

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie